chrX-154411891-C-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PP3_ModerateBP6_Very_StrongBS2
The ENST00000309585.9(DNASE1L1):c.-173G>C variant causes a splice region, 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000415 in 1,205,714 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
ENST00000309585.9 splice_region, 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAFAZZIN | NM_000116.5 | c.48C>G | p.Thr16= | synonymous_variant | 1/11 | ENST00000601016.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAFAZZIN | ENST00000601016.6 | c.48C>G | p.Thr16= | synonymous_variant | 1/11 | 1 | NM_000116.5 |
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112350Hom.: 0 Cov.: 23 AF XY: 0.0000579 AC XY: 2AN XY: 34516
GnomAD3 exomes AF: 0.00000605 AC: 1AN: 165304Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 57492
GnomAD4 exome AF: 0.00000183 AC: 2AN: 1093364Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 360532
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112350Hom.: 0 Cov.: 23 AF XY: 0.0000579 AC XY: 2AN XY: 34516
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 15, 2010 | - - |
3-Methylglutaconic aciduria type 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 19, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 14, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at